Anti-Arrhythmic Drug Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Oral Antiarrhythmic, Intravenous Antiarryhthmic); End User (Hospitals, Clinics, Homecare) and Geography

Report Code: TIPRE00017071 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

Anti-arrhythmic drugs help manage abnormal rhythm resulting from the heart's irregular electrical activity due to atrial flutter and atrial and ventricular fibrillation. All antiarrhythmic drugs directly or indirectly alter membrane ion conductance, which changes cardiac action potential and physical characteristics.

MARKET DYNAMICS

Factors like increasing obesity cases worldwide, rising cardiovascular issues among the population, neglect towards regular exercise, and high-stress levels will propel the market growth. However, side effects caused by antiarrhythmics like nausea or headache will hamper market growth.

MARKET SCOPE

The "Anti-Arrhythmic Drug Market Analysis to 2028" is a specialized and in-depth study of the Pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of anti-arrhythmic drug market with detailed market segmentation with type and end user. The anti-arrhythmic drug market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in anti-arrhythmic drug market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The anti-arrhythmic drug market is segmented on the basis of type and end user. On the basis of type, the anti-arrhythmic drug market is divided into oral antiarrhythmic and intravenous antiarrhythmic. Based on end user, the anti-arrhythmic drug market can be segmented as hospitals, clinics and home care.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the anti-arrhythmic drug market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The anti-arrhythmic drug market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyses factors affecting anti-arrhythmic drug market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors affecting the anti-arrhythmic drug market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in anti-arrhythmic drug market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from anti-arrhythmic drug market are anticipated to have lucrative growth opportunities in the future with the rising demand for anti-arrhythmic drugs in the global market. Below mentioned is the list of few companies engaged in the anti-arrhythmic drug market.

The report also includes the profiles of key players in anti-arrhythmic drug market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.

    ?Novartis AG
    ?Merck and Co., Inc.
    ?Pfizer Inc.
    ?Astra Zeneca
    ?Johnson and Johnson Services, Inc.
    ?Teva Pharmaceutical Industries Ltd.
    ?Eli Lilly and Company.
    ?Sanofi S.A. 
    ?Bayer AG
    ?GlaxoSmithKline plc

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Anti-Arrhythmic Drug Market - By Type
1.3.2 Anti-Arrhythmic Drug Market - By End User
1.3.3 Anti-Arrhythmic Drug Market - By Region
1.3.3.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. ANTI-ARRHYTHMIC DRUG MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. ANTI-ARRHYTHMIC DRUG MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. ANTI-ARRHYTHMIC DRUG MARKET - GLOBAL MARKET ANALYSIS
6.1. ANTI-ARRHYTHMIC DRUG - GLOBAL MARKET OVERVIEW
6.2. ANTI-ARRHYTHMIC DRUG - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE

7. ANTI-ARRHYTHMIC DRUG MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. ORAL ANTIARRHYTHMIC
7.3.1. Overview
7.3.2. Oral Antiarrhythmic Market Forecast and Analysis
7.4. INTRAVENOUS ANTIARRYHTHMIC
7.4.1. Overview
7.4.2. Intravenous Antiarryhthmic Market Forecast and Analysis
8. ANTI-ARRHYTHMIC DRUG MARKET - REVENUE AND FORECASTS TO 2028 - END USER
8.1. OVERVIEW
8.2. END USER MARKET FORECASTS AND ANALYSIS
8.3. HOSPITALS
8.3.1. Overview
8.3.2. Hospitals Market Forecast and Analysis
8.4. CLINICS
8.4.1. Overview
8.4.2. Clinics Market Forecast and Analysis
8.5. HOMECARE
8.5.1. Overview
8.5.2. Homecare Market Forecast and Analysis

9. ANTI-ARRHYTHMIC DRUG MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Anti-Arrhythmic Drug Market Overview
9.1.2 North America Anti-Arrhythmic Drug Market Forecasts and Analysis
9.1.3 North America Anti-Arrhythmic Drug Market Forecasts and Analysis - By Type
9.1.4 North America Anti-Arrhythmic Drug Market Forecasts and Analysis - By End User
9.1.5 North America Anti-Arrhythmic Drug Market Forecasts and Analysis - By Countries
9.1.5.1 United States Anti-Arrhythmic Drug Market
9.1.5.1.1 United States Anti-Arrhythmic Drug Market by Type
9.1.5.1.2 United States Anti-Arrhythmic Drug Market by End User
9.1.5.2 Canada Anti-Arrhythmic Drug Market
9.1.5.2.1 Canada Anti-Arrhythmic Drug Market by Type
9.1.5.2.2 Canada Anti-Arrhythmic Drug Market by End User
9.1.5.3 Mexico Anti-Arrhythmic Drug Market
9.1.5.3.1 Mexico Anti-Arrhythmic Drug Market by Type
9.1.5.3.2 Mexico Anti-Arrhythmic Drug Market by End User
9.2. EUROPE
9.2.1 Europe Anti-Arrhythmic Drug Market Overview
9.2.2 Europe Anti-Arrhythmic Drug Market Forecasts and Analysis
9.2.3 Europe Anti-Arrhythmic Drug Market Forecasts and Analysis - By Type
9.2.4 Europe Anti-Arrhythmic Drug Market Forecasts and Analysis - By End User
9.2.5 Europe Anti-Arrhythmic Drug Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Anti-Arrhythmic Drug Market
9.2.5.1.1 Germany Anti-Arrhythmic Drug Market by Type
9.2.5.1.2 Germany Anti-Arrhythmic Drug Market by End User
9.2.5.2 France Anti-Arrhythmic Drug Market
9.2.5.2.1 France Anti-Arrhythmic Drug Market by Type
9.2.5.2.2 France Anti-Arrhythmic Drug Market by End User
9.2.5.3 Italy Anti-Arrhythmic Drug Market
9.2.5.3.1 Italy Anti-Arrhythmic Drug Market by Type
9.2.5.3.2 Italy Anti-Arrhythmic Drug Market by End User
9.2.5.4 Spain Anti-Arrhythmic Drug Market
9.2.5.4.1 Spain Anti-Arrhythmic Drug Market by Type
9.2.5.4.2 Spain Anti-Arrhythmic Drug Market by End User
9.2.5.5 United Kingdom Anti-Arrhythmic Drug Market
9.2.5.5.1 United Kingdom Anti-Arrhythmic Drug Market by Type
9.2.5.5.2 United Kingdom Anti-Arrhythmic Drug Market by End User
9.2.5.6 Rest of Europe Anti-Arrhythmic Drug Market
9.2.5.6.1 Rest of Europe Anti-Arrhythmic Drug Market by Type
9.2.5.6.2 Rest of Europe Anti-Arrhythmic Drug Market by End User
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Anti-Arrhythmic Drug Market Overview
9.3.2 Asia-Pacific Anti-Arrhythmic Drug Market Forecasts and Analysis
9.3.3 Asia-Pacific Anti-Arrhythmic Drug Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Anti-Arrhythmic Drug Market Forecasts and Analysis - By End User
9.3.5 Asia-Pacific Anti-Arrhythmic Drug Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Anti-Arrhythmic Drug Market
9.3.5.1.1 Australia Anti-Arrhythmic Drug Market by Type
9.3.5.1.2 Australia Anti-Arrhythmic Drug Market by End User
9.3.5.2 China Anti-Arrhythmic Drug Market
9.3.5.2.1 China Anti-Arrhythmic Drug Market by Type
9.3.5.2.2 China Anti-Arrhythmic Drug Market by End User
9.3.5.3 India Anti-Arrhythmic Drug Market
9.3.5.3.1 India Anti-Arrhythmic Drug Market by Type
9.3.5.3.2 India Anti-Arrhythmic Drug Market by End User
9.3.5.4 Japan Anti-Arrhythmic Drug Market
9.3.5.4.1 Japan Anti-Arrhythmic Drug Market by Type
9.3.5.4.2 Japan Anti-Arrhythmic Drug Market by End User
9.3.5.5 South Korea Anti-Arrhythmic Drug Market
9.3.5.5.1 South Korea Anti-Arrhythmic Drug Market by Type
9.3.5.5.2 South Korea Anti-Arrhythmic Drug Market by End User
9.3.5.6 Rest of Asia-Pacific Anti-Arrhythmic Drug Market
9.3.5.6.1 Rest of Asia-Pacific Anti-Arrhythmic Drug Market by Type
9.3.5.6.2 Rest of Asia-Pacific Anti-Arrhythmic Drug Market by End User
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Anti-Arrhythmic Drug Market Overview
9.4.2 Middle East and Africa Anti-Arrhythmic Drug Market Forecasts and Analysis
9.4.3 Middle East and Africa Anti-Arrhythmic Drug Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Anti-Arrhythmic Drug Market Forecasts and Analysis - By End User
9.4.5 Middle East and Africa Anti-Arrhythmic Drug Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Anti-Arrhythmic Drug Market
9.4.5.1.1 South Africa Anti-Arrhythmic Drug Market by Type
9.4.5.1.2 South Africa Anti-Arrhythmic Drug Market by End User
9.4.5.2 Saudi Arabia Anti-Arrhythmic Drug Market
9.4.5.2.1 Saudi Arabia Anti-Arrhythmic Drug Market by Type
9.4.5.2.2 Saudi Arabia Anti-Arrhythmic Drug Market by End User
9.4.5.3 U.A.E Anti-Arrhythmic Drug Market
9.4.5.3.1 U.A.E Anti-Arrhythmic Drug Market by Type
9.4.5.3.2 U.A.E Anti-Arrhythmic Drug Market by End User
9.4.5.4 Rest of Middle East and Africa Anti-Arrhythmic Drug Market
9.4.5.4.1 Rest of Middle East and Africa Anti-Arrhythmic Drug Market by Type
9.4.5.4.2 Rest of Middle East and Africa Anti-Arrhythmic Drug Market by End User
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Anti-Arrhythmic Drug Market Overview
9.5.2 South and Central America Anti-Arrhythmic Drug Market Forecasts and Analysis
9.5.3 South and Central America Anti-Arrhythmic Drug Market Forecasts and Analysis - By Type
9.5.4 South and Central America Anti-Arrhythmic Drug Market Forecasts and Analysis - By End User
9.5.5 South and Central America Anti-Arrhythmic Drug Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Anti-Arrhythmic Drug Market
9.5.5.1.1 Brazil Anti-Arrhythmic Drug Market by Type
9.5.5.1.2 Brazil Anti-Arrhythmic Drug Market by End User
9.5.5.2 Argentina Anti-Arrhythmic Drug Market
9.5.5.2.1 Argentina Anti-Arrhythmic Drug Market by Type
9.5.5.2.2 Argentina Anti-Arrhythmic Drug Market by End User
9.5.5.3 Rest of South and Central America Anti-Arrhythmic Drug Market
9.5.5.3.1 Rest of South and Central America Anti-Arrhythmic Drug Market by Type
9.5.5.3.2 Rest of South and Central America Anti-Arrhythmic Drug Market by End User

10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

11. ANTI-ARRHYTHMIC DRUG MARKET, KEY COMPANY PROFILES
11.1. NOVARTIS AG
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. MERCK AND CO., INC.
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. PFIZER INC.
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. ASTRA ZENECA
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. JOHNSON AND JOHNSON SERVICES, INC.
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. TEVA PHARMACEUTICAL INDUSTRIES LTD.
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. ELI LILLY AND COMPANY.
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. SANOFI S.A. 
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. BAYER AG
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. GLAXOSMITHKLINE PLC
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments

12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. Novartis AG
2. Merck and Co., Inc.
3. Pfizer Inc.
4. Astra Zeneca
5. Johnson and Johnson Services, Inc.
6. Teva Pharmaceutical Industries Ltd.
7. Eli Lilly and Company.
8. Sanofi S.A.
9. Bayer AG
10. GlaxoSmithKline plc
TIPRE00017071
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking